Skip to content

Establishment of diagnostic model and evaluation of clinical effect of adenomyosis subtype based on artificial intelligence technology

Establishment of diagnostic model and evaluation of clinical effect of adenomyosis subtype based on AI technology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118428
Enrollment
Unknown
Registered
2026-02-05
Start date
2025-01-02
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea, adenomyosis

Interventions

Observation Group (Magnetic Resonance Kishi Classification and subclassification of adenomyosis):None

Sponsors

Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 56 Years

Inclusion criteria

Inclusion criteria: 1.Patients with adenomyosis diagnosed by MRI in our hospital, who are fully aware of the purpose, nature, method and possible adverse reactions of the test, voluntarily serve as subjects, sign informed consent before any research procedure, and guarantee that they will participate in the study in any procedure. 2.Symptomatic adenomyosis patients aged 18-56 years (including 18 and 56 years) with no need for fertility. 3.The subject is able to communicate well with the investigator and understand and comply with the requirements of the study.

Exclusion criteria

Exclusion criteria: 1.Those who cannot communicate well with the researchers, fail to understand or do not comply with the various requirements of this study. 2.Those who were lost to follow-up due to the subjects' unilateral reasons or whose follow-up data were missing.

Design outcomes

Primary

MeasureTime frame
Symptom and health score;Pain score;Menstrual blood volume;The accuracy and specificity of the diagnostic model for subtypes of adenomyosis;

Secondary

MeasureTime frame
Magnetic resonance imaging data(Kishi classification and uterine volume, etc.);Hemoglobin;CA125;Evaluation of the effect and economics of personalized treatment for adenomyosis;

Countries

China

Contacts

Public ContactWei Wenjiang

Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)

147weiwenjiang@sina.com+86 20 89169379

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026